Sort
48,018 grants matching “immunotherapy”
Biomimetic Matrix for Ex Vivo and In Vivo Activation of T Cells
$479,444Hai-Quan Mao · Johns Hopkins University · R01 · FY2020 · EB
Biomimetic Matrix for Ex Vivo and In Vivo Activation of T Cells
$479,444Hai-Quan Mao · Johns Hopkins University · R01 · FY2023 · EB
Drug Mechanism of Action-based targeting of tumor subpopulations
$479,435Andrea Califano · Columbia University Health Sciences · U54 · FY2023 · CA
Role of Dendritic Cell-mediated T Cell Activation in Salt-sensitive Hypertension
$479,391Steven D Crowley · Duke University · R01 · FY2017 · HL
Quantitative modeling of the phenotypic variability of individual T cells and the
$479,391Gregoire Altan-Bonnet · Sloan-Kettering Inst Can Research · R01 · FY2011 · AI
Investigating the neutrophil-sensory neuron crosstalk in lung cancer
$479,389Chengcheng Jin · University Of Pennsylvania · R01 · FY2025 · CA
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
$479,375Michael A Caligiuri · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
$479,375Michael A Caligiuri · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Autophagy proteins in the immune response to Mycobacterium tuberculosis infection
$479,339Christina Leigh Stallings · Washington University · R01 · FY2020 · AI
B7-H1/PD-1 modulation in cancer therapy
$479,334Drew M. Pardoll · Johns Hopkins University · R01 · FY2011 · CA
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
$479,283Andre Elias Nel · University Of California Los Angeles · R01 · FY2024 · CA
Developing new therapeutic strategies for pediatric tumors that lack clinically actionable mutations
$479,150Paul Geeleher · St. Jude Children'S Research Hospital · R01 · FY2025 · CA
Nanoscale Metal-Organic Frameworks Enable Radiotherapy-Radiodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Generate Tumor Vaccines and Potentiate Immunotherapy of Head and Neck Cancers
$479,142Wenbin Lin · University Of Chicago · R01 · FY2024 · CA
Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2025 · AI
Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2023 · AI
Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2024 · AI
Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2025 · AI
Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2023 · AI
Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2024 · AI
Reducing racial disparities and achieving health equity in lung cancer treatment among the underserved
$478,977Dale Sharon Hardy · Morehouse School Of Medicine · R01 · FY2024 · MD
Breast Cancer Treatment with Antibody Targeted T Cells
$478,954Lawrence G Lum · Wayne State University · R01 · FY2012 · CA
Gasdermin E and pyroptosis in cancer
$478,863Judy Lieberman · Boston Children'S Hospital · R01 · FY2024 · CA
Dissecting the pathways controlling tunable responses to TCR signaling
$478,861Leslie J. Berg · University Of Colorado Denver · R01 · FY2021 · AI
Dissecting the pathways controlling tunable responses to TCR signaling
$478,861Leslie J. Berg · University Of Colorado Denver · R01 · FY2022 · AI
Targeting innate immune pathways in breast cancers with chromosomal instability
$478,720Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA